Results 61 to 70 of about 3,490 (164)
Objective: To evaluate the success rates of tamsulosin and dutasteride as medical therapy based on international prostate symptom score (IPSS) in symptomatic benign prostatic hyperplasia (BPH) patients. Materials & Methods: We reviewed medical records of
Zuhirman Zamzami
doaj +1 more source
Objectives: to find the efficacy dutasteride and green tea in reducing hemorrhage on TURP patients and to evaluate the anti- angiogenesis effect. Methods: Double Blind Randomized Controlled Trial Post Test Only, with 80 samples, randomized into 4 ...
Eriawan Agung Nugroho +3 more
doaj +1 more source
Min-Soo KimDepartment of Pharmaceutical Engineering, Inje University, Gimhae, Gyeongnam, Republic of KoreaAbstract: The objectives of this study were to develop a novel solid dutasteride formulation with improved physicochemical properties and oral ...
Kim MS
doaj
Background Dutasteride is used to treat voiding symptoms; its impact on storage symptoms is unclear.Methods We reviewed 8122 men in the placebo and dutasteride arms from the REDUCE trial.
Alexander Hernandez-Tirado +5 more
doaj +1 more source
Objective: To compare the PSA and TGF-β1 plasma level before and after administration of a 5α-reductase inhibitor (dutasteride) and an anti estrogen (tamoxifen) in nonobstructive patients with BPH.
Rachmat Budi Prasetyo +2 more
doaj +1 more source
Objective: To compare the IPSS, Q max, and volume of the prostate pre and post treatment of 5α-reductase inhibitor and tamoxyfen in patients with BPH. Material and Methods: We collected 40 patients who had been diagnosed as BPH without urine retention ...
Kurnia Penta Seputra +2 more
doaj +1 more source
Effect of Dutasteride on the Risk of Prostate Cancer
We conducted a study to determine whether dutasteride reduces the risk of incident prostate cancer, as detected on biopsy, among men who are at increased risk for the disease.In this 4-year, multicenter, randomized, double-blind, placebo-controlled, parallel-group study, we compared dutasteride, at a dose of 0.5 mg daily, with placebo.
Andriole, G.L. +16 more
openaire +8 more sources
Purpose: The current study is aimed to assess whether a longer duration of 5α-reductase inhibitor (5α-RI) exposure was asso-ciated with higher rate of permanent erectile dysfunction (ED) in a rat model.
Hyun Hwan Sung +6 more
doaj +1 more source
Zhongbao Zhou,1,2,* Shiqiang Song,3,* Zhenli Gao,2 Jitao Wu,2 Jiajia Ma,2 Yuanshan Cui2 1School of clinical medicine, Binzhou Medical University, Yantai, Shandong, China; 2Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao ...
Zhou Z, Song S, Gao Z, Wu J, Ma J, Cui Y
doaj
. Background. Only a few reports have currently studied the efficacy of dutasteride in patients with small benign prostatic hyperplasia (BPH). We investigated the efficacy of dutasteride on reducing lower urinary tract symptoms among them.
Kazuyoshi Shigehara +5 more
doaj +1 more source

